ReviewCurrent hematologic malignancy reports2018

CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.

Katherine C Pehlivan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.